| P2093 | author name string | Alexander Storch | |
| | Andreas Hermann | |
| P2860 | cites work | Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells | Q24632072 |
| | Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 |
| | Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 |
| | Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 |
| | Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | Q26269888 |
| | Induction of human neuronal cells by defined transcription factors | Q26269896 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 |
| | Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression | Q42823656 |
| | Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. | Q48348076 |
| | Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of γ-secretase activity in endogenous amyloid-β generation. | Q48563855 |
| | Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols. | Q50940919 |
| | Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. | Q51825556 |
| | Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells | Q80436736 |
| | Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells | Q84431119 |
| | Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 |
| | Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 |
| | Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 |
| | Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 |
| | Induced pluripotent stem cells generated without viral integration | Q29614343 |
| | Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming | Q29614416 |
| | Direct generation of functional dopaminergic neurons from mouse and human fibroblasts | Q29616184 |
| | Somatic coding mutations in human induced pluripotent stem cells | Q29616798 |
| | Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 |
| | Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin | Q29619238 |
| | Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors | Q30514064 |
| | Small molecules enable highly efficient neuronal conversion of human fibroblasts | Q34031414 |
| | Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells | Q34067970 |
| | Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats | Q34115609 |
| | Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators | Q34124072 |
| | Direct reprogramming of mouse fibroblasts to neural progenitors | Q34180572 |
| | Direct conversion of human fibroblasts to dopaminergic neurons | Q34190302 |
| | Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | Q34236195 |
| | Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 |
| | Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 |
| | Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor | Q34280164 |
| | An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells | Q34314350 |
| | Neural stem cells and neurodegeneration | Q34713980 |
| | Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors | Q34791180 |
| | Oct4-induced pluripotency in adult neural stem cells. | Q34940495 |
| | Variation in the safety of induced pluripotent stem cell lines | Q34991636 |
| | Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons | Q35151670 |
| | Direct reprogramming of human astrocytes into neural stem cells and neurons. | Q36118372 |
| | Optimal ratio of transcription factors for somatic cell reprogramming. | Q36332879 |
| | Epigenetic conversion of human adult bone mesodermal stromal cells into neuroectodermal cell types for replacement therapy of neurodegenerative disorders | Q36521826 |
| | Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles | Q36781956 |
| | Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. | Q37345661 |
| | Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. | Q37401842 |
| | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits | Q39211798 |
| | Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors | Q39668347 |
| | Direct reprogramming of human neural stem cells by OCT4. | Q39806256 |
| | Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector | Q40541181 |
| | Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease | Q42818202 |
| P921 | main subject | neurodegeneration | Q1755122 |
| | neural stem cell | Q2944097 |
| P304 | page(s) | S19-25 | |
| P577 | publication date | 2013-05-30 | |
| P1433 | published in | Journal of Neural Transmission | Q15750921 |
| P1476 | title | Induced neural stem cells (iNSCs) in neurodegenerative diseases | |
| P478 | volume | 120 Suppl 1 | |